Primary Pulmonary Hypertension

Primary pulmonary hypertension(PPH) is a rare disease. The annual incidence in the West is 1-2 cases per million population per year. A recent WHO symposium in 1998 has produced a consensus on classification, methods of screening, risk assessment and treatment. PPH is a diagnosis of exclusion after...

Full description

Bibliographic Details
Main Author: Abdul Rani, Mohammed Fauzi
Format: Article
Language:English
Published: Malaysian Medical Association 2000
Subjects:
Online Access:http://irep.iium.edu.my/5876/
http://irep.iium.edu.my/5876/1/Primary_Pulmonary_Hypertension.pdf
_version_ 1848776580218748928
author Abdul Rani, Mohammed Fauzi
author_facet Abdul Rani, Mohammed Fauzi
author_sort Abdul Rani, Mohammed Fauzi
building IIUM Repository
collection Online Access
description Primary pulmonary hypertension(PPH) is a rare disease. The annual incidence in the West is 1-2 cases per million population per year. A recent WHO symposium in 1998 has produced a consensus on classification, methods of screening, risk assessment and treatment. PPH is a diagnosis of exclusion after all other secondary causes of pulmonary hypertension are ruled out. Current treatment strategy involves acute vasodilator drug trial where positive responders are treated with high dose calcium channel blockers and anticoagulation. Those who do not show positive response may be commenced on intravenous prostacyclin. Surgical treatment is one option for patients with severe PPH or for symptomatic relief. Prognosis in general is very poor.
first_indexed 2025-11-14T14:32:21Z
format Article
id iium-5876
institution International Islamic University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T14:32:21Z
publishDate 2000
publisher Malaysian Medical Association
recordtype eprints
repository_type Digital Repository
spelling iium-58762013-06-26T00:21:27Z http://irep.iium.edu.my/5876/ Primary Pulmonary Hypertension Abdul Rani, Mohammed Fauzi R Medicine (General) Primary pulmonary hypertension(PPH) is a rare disease. The annual incidence in the West is 1-2 cases per million population per year. A recent WHO symposium in 1998 has produced a consensus on classification, methods of screening, risk assessment and treatment. PPH is a diagnosis of exclusion after all other secondary causes of pulmonary hypertension are ruled out. Current treatment strategy involves acute vasodilator drug trial where positive responders are treated with high dose calcium channel blockers and anticoagulation. Those who do not show positive response may be commenced on intravenous prostacyclin. Surgical treatment is one option for patients with severe PPH or for symptomatic relief. Prognosis in general is very poor. Malaysian Medical Association 2000-12-04 Article NonPeerReviewed application/pdf en http://irep.iium.edu.my/5876/1/Primary_Pulmonary_Hypertension.pdf Abdul Rani, Mohammed Fauzi (2000) Primary Pulmonary Hypertension. Medical Journal Malaysia, 55 (4). pp. 529-537. ISSN 0300-5283 http://www.e-mjm.org/2000/v55n4/Primary_Pulmonary_Hypertension.pdf http://www.e-mjm.org/2000/v55n4/Primary_Pulmonary_Hypertension.pdf
spellingShingle R Medicine (General)
Abdul Rani, Mohammed Fauzi
Primary Pulmonary Hypertension
title Primary Pulmonary Hypertension
title_full Primary Pulmonary Hypertension
title_fullStr Primary Pulmonary Hypertension
title_full_unstemmed Primary Pulmonary Hypertension
title_short Primary Pulmonary Hypertension
title_sort primary pulmonary hypertension
topic R Medicine (General)
url http://irep.iium.edu.my/5876/
http://irep.iium.edu.my/5876/
http://irep.iium.edu.my/5876/
http://irep.iium.edu.my/5876/1/Primary_Pulmonary_Hypertension.pdf